ONE person has been left brain dead and five others have suffered serious health complications after taking part in medical trials for an unnamed pharmaceutical firm.
All six patients were alleged to have been in good health before the trials started at a reputable Biotrial clinic in Rennes, Brittany, but quickly fell sick after taking tablets thought to contain cannabinoids, the psychoactive ingredient in Marijuana.
The French health ministry has confirmed that an inquiry into the accident will be opened by the state prosecutor and that all further trails of the drug have been suspended for the foreseeable future.
Marijuana is currently gaining global attention for its properties as a pain reliever. Many legal users anticipate the day when it becomes available in tablet form, so these unfortunate developments will serve as a major setback to this research.